ACRO BIOMEDICAL CO., LTD. Quarterly Current Ratio in % from Q4 2016 to Q2 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Acro Biomedical Co., Ltd. quarterly Current Ratio history and growth rate from Q4 2016 to Q2 2023.
  • Acro Biomedical Co., Ltd. Current Ratio for the quarter ending June 30, 2023 was 307 %, a 65% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 307 -570 -65% Jun 30, 2023
Q1 2023 376 -590 -61.1% Mar 31, 2023
Q4 2022 521 -40.2 -7.16% Dec 31, 2022
Q3 2022 682 +252 +58.4% Sep 30, 2022
Q2 2022 877 +494 +129% Jun 30, 2022
Q1 2022 966 +597 +162% Mar 31, 2022
Q4 2021 561 +106 +23.2% Dec 31, 2021
Q3 2021 431 -152 -26% Sep 30, 2021
Q2 2021 383 -261 -40.5% Jun 30, 2021
Q1 2021 368 -340 -48% Mar 31, 2021
Q4 2020 456 -248 -35.3% Dec 31, 2020
Q3 2020 582 -197 -25.2% Sep 30, 2020
Q2 2020 644 -144 -18.3% Jun 30, 2020
Q1 2020 708 +38.2 +5.71% Mar 31, 2020
Q4 2019 704 +117 +20% Dec 31, 2019
Q3 2019 779 +298 +62% Sep 30, 2019
Q2 2019 789 +300 +61.3% Jun 30, 2019
Q1 2019 670 +184 +37.9% Mar 31, 2019
Q4 2018 587 +79.8 +15.8% Dec 31, 2018
Q3 2018 481 -21.3 -4.23% Sep 30, 2018
Q2 2018 489 +478 +4613% Jun 30, 2018
Q1 2018 486 +473 +3632% Mar 31, 2018
Q4 2017 507 +473 +1399% Dec 31, 2017
Q3 2017 502 Sep 30, 2017
Q2 2017 10.4 Jun 30, 2017
Q1 2017 13 Mar 31, 2017
Q4 2016 33.8 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.